Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Cybulsky AV
The metabolic therapeutics field will be shaped significantly by whether retatrutide's Phase 3 results validate its Phase 2 promise, potentially establishing triple agonism as the next evolution beyond semaglutide's proven single-agonist approach
Researchers are investigating retatrutide as a potential treatment for several metabolic conditions, including[2,3]: Type 2 diabetes Obesity Fatty liver disease Fatty liver disease is commonly linked to obesity, alcohol use, and diabetes
Conditions that need clinician oversight Personal or family history of medullary thyroid carcinoma or MEN 2
In the scientific literature, the molecule is described as a single peptide with a multi-receptor profile of action, designed to simultaneously modulate several key metabolic axes
Se vende con distintos nombres comerciales, entre ellos Ozempic , Rybelsus, Wegovy y Dutide
US$ 21.26
US$ 20.76
US$ 20.91
US$ 26.70
.png)
US$ 26.91
US$ 24.86
